Paronychia Treatment Market : Extensive Analysis of the Current & Emerging Market Trends

Market Analysis 

The global paronychia treatment market is predicted to grow at an 11.7% CAGR over the forecast period (2017-2023), states the new Market Research Future (MRFR) report. Paronychia, simply put, is a skin infection that develops surrounding the nail. This happens when fungi or bacteria gets under the skin. It can result from chewing or biting the nails, yet it is common during working conditions that need the hands in being frequently exposed to chemicals or is frequently wet. Most often, paronychia is not a serious condition, and there are many effective treatments. This skin infection results in discomfort, swelling, and inflammation around the nail. In paronychia abscesses having pus may also form. 

Regional Analysis

By region, the paronychia treatment market report covers the latest trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will have the lion’s share in the market over the forecast period. Factors aiding growth in the region include growing prevalence of pyogenic paronychia, candida paronychia, chronic paronychia, and acute paronychia, growing support from the government for R&D activities, well-developed technology, changing lifestyle, and high healthcare expenditure. Moreover, the presence of key players in the region is also accelerating market growth. 

The paronychia treatment market in Europe will have the second-largest share over the forecast period. Factors aiding growth in the region include strong government support, availability of funds for R&D activities, and the presence of several key players in the region. 

The paronychia treatment market in the APAC region is predicted to grow at the fastest pace over the forecast period. Factors aiding growth in the region include increasing government support, rapidly developing economy, and growing healthcare awareness. Moreover, growing demand for new treatments in South Korea and India, increasing patient population, and government in the developing countries focusing on quality treatment to improve the citizens’ living standard. 

On the flip side, the paronychia treatment market in the Middle East and Africa will have a small share in the market over the forecast period. This is chiefly due to the limited availability of medical facilities and funds and poor political conditions, especially in Africa. The Middle East region will lead the market. South Arabia, Oman, Qatar, and Kuwait are the chief contributors in the region. The African region, on the contrary, is predicted to have stable growth as there is enough scope for the market to develop. 

Key Players

Leading players profiled in the paronychia treatment market report include Perrigo New York, Inc. (US), Taro Pharmaceutical Industries Ltd. (US), Fougera Pharmaceuticals Inc. (US), Jonakayem Pharma Formulation Pvt. Ltd. (India), Eli Lilly Company (US), Teva Pharmaceutical Industries Ltd. (Israel), Glenmark Generics Ltd. (India), and GlaxoSmithKline plc (UK). Various strategies such as partnerships/joint ventures, mergers and acquisitions, research and development activities, product launches and innovations, and more have been incorporated by top players to create a foothold in the market. 

Article source: https://article-realm.com/article/Sports-Recreation/13284-Paronychia-Treatment-Market-Extensive-Analysis-of-the-Current-and-Emerging-Market-Trends.html